FDA’s Promotional Assessments Reorganized Around Specialty, Not Target Audience
This article was originally published in The Pink Sheet Daily
Executive Summary
The two divisions within the Office of Prescription Drug Promotion are renamed the divisions of advertising and promotion review I and II; they will each have four teams operating within them in a structure akin to the Office of New Drugs.